Iometopane

N/A

Report date: 2025/12/01 17:16:56
NME

Base Information

Drug NameIometopane
Drug Alias NameIometopane I 123Dopascan Injection123I-RTI-55Dopascan[123I]beta-CIT +[8] 
ClassificationDiagnostic agent (In vivo)Small moleculesRadiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of ActionSerotonin transporter inhibitorsDopamine transporter antagonists
TargetsDopamine transporterSerotonin transporter
Therapy Area/IndicationsParkinson DiseaseParkinsonian Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesResearch Triangle Inst
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Institute For Neurodegenerative Disorders Inc
Active IndicationsN/A
Inactive IndicationsParkinson DiseaseParkinsonian Disorders

Other Information

ATC CodeN/A
Related LinksN/A